NASALIDE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Nasalide, and when can generic versions of Nasalide launch?

Nasalide is a drug marketed by Ivax Res and is included in one NDA.

The generic ingredient in NASALIDE is flunisolide. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the flunisolide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Nasalide

A generic version of NASALIDE was approved as flunisolide by BAUSCH on February 20^th, 2002.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NASALIDE?
What are the global sales for NASALIDE?
What is Average Wholesale Price for NASALIDE?

Summary for NASALIDE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	48
Patent Applications:	4,440
DailyMed Link:	NASALIDE at DailyMed

Drug patent expirations by year for NASALIDE

US Patents and Regulatory Information for NASALIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ivax Res	NASALIDE	flunisolide	SPRAY, METERED;NASAL	018148-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NASALIDE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ivax Res	NASALIDE	flunisolide	SPRAY, METERED;NASAL	018148-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for NASALIDE

See the table below for patents covering NASALIDE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
United Kingdom	1525181		⤷ Sign Up
Israel	49652	PHARMACEUTICAL COMPOSITIONS CONTAINING FLUNISOLIDE FOR TREATING RESPIRATORY DESEASES	⤷ Sign Up
South Africa	7603131		⤷ Sign Up
Malaysia	8000275	NEW FORM OF FLUNISOLIDE AND THE USE OF FLUNISOLIDE TO TREAT RESPIRATORY DISEASES	⤷ Sign Up
Netherlands	7605699		⤷ Sign Up
Philippines	13329	STABLE CRYSTALLINE PLYNISOLIDE AND COMPOSITION THEREOF	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for NASALIDE

Make Better Decisions: Try a trial or see plans & pricing